Obstetrics and Gynecology · 2006 · 10 citations · 6 references
MedicineObstetricsPharmacologyMaternal-fetal MedicineObstetric HemorrhageObstetric SurgeryHypertensive DisordersMaternal Medical Complications In PregnancyPerinatal PharmacologyPregnancyPregnancy PharmacologyPregnancy-induced HypertensionAbrupt CessationAngiotensin Ii Receptor BlockersAntihypertensive PharmacologyAntihypertensive TreatmentObstetric ThromboprophylaxisPerinatal ThrombosisPregnancy-associated ThromboprophylaxisPregnancy-related Blood Pressure Regulation
In Brief BACKGROUND: Angiotensin receptor blockers are antihypertensive medications prescribed by a wide variety of physicians, especially for patients with coexistent diabetes mellitus. Angiotensin receptor blockers, as well as angiotensin-converting enzyme inhibitors, are contraindicated in pregnancy. CASE: We describe the reversal of losartan-induced oligohydramnios at 27 weeks of gestation with subsequent development of fetal thrombosis and possible mechanism of action for this extremely rare in utero complication. CONCLUSION: This theory may help explain the fetal stillbirths in women taking this class of medications during the second and third trimester of pregnancy. Development of a fetal inferior vena cava thrombosis appears temporally related to abrupt cessation of angiotensin receptor blocker use during pregnancy.
6
Paul M. Ridker, Cynthia L. Gaboury, Paul R. Conlin et al. · Circulation · 1993 · 405 citations
Medicine, Cardiology, Pharmacology +15
Antithrombotic Effect of Captopril and Losartan Is Mediated by Angiotensin-(1-7)
Iwona Kucharewicz, Robert Pawlak, Tomasz Matys et al. · Hypertension · 2002 · 131 citations · Full text
Medicine, Cardiology, Pharmacology +11
The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats.
Ewa Chabielska, Robert Pawlak, J Golatowski et al. · PubMed · 1998 · 24 citations
Medicine, Cardiology, Pharmacology +17